Prestige Consumer Healthcare (PBH) Net Margin Growth (3y) (2013 - 2025)
Prestige Consumer Healthcare (PBH) Net Margin Growth (3y) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 948.00 |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -491.00 |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 83.00 |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | -94.00 |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -990.00 |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | -604.00 |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 1,312.00 |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Prestige Consumer Healthcare | 2.43 Bn | 2.36 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -238.00 |
| Sep 30, 2025 | -224.00 |
| Jun 30, 2025 | -93.00 |
| Mar 31, 2025 | -261.00 |
| Dec 31, 2024 | 273.00 |
| Sep 30, 2024 | 275.00 |
| Jun 30, 2024 | -309.00 |
| Mar 31, 2024 | 292.00 |
| Dec 31, 2023 | 164.00 |
| Sep 30, 2023 | -7.00 |
| Jun 30, 2023 | 2.00 |
| Mar 31, 2023 | -9,889.00 |
| Dec 31, 2022 | 310.00 |
| Sep 30, 2022 | 367.00 |
| Jun 30, 2022 | 534.00 |
| Mar 31, 2022 | 7,730.00 |
| Dec 31, 2021 | 249.00 |
| Sep 30, 2021 | 352.00 |
| Jun 30, 2021 | 789.00 |
| Mar 31, 2021 | 3,044.00 |